Want to see JP:4526 full AI Analyst Report?
Riken Vitamin Co., Ltd. (4526) AI Stock Analysis
Riken Vitamin Co., Ltd.
(TSE/TYO:4526)
The overall score of 70 reflects a solid investment case supported by strong technical momentum and attractive valuation, tempered by moderate financial performance due to recent declines in profitability and cash flow. The company's robust balance sheet provides a safety net.
Riken Vitamin Co., Ltd. (4526) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 99.87B
- Dividend Yield
- 3.20%
- Average Volume (3M)
- 90.84K
- Price to Earnings (P/E)
- 14.3
- Beta (1Y)
- 0.35
- Revenue Growth
- 3.11%
- EPS Growth
- -17.81%
- Country
- Japan
- Employees
- 1,887
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Packaged Foods
Riken Vitamin Co., Ltd. Business Overview & Revenue Model
Company Description
Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used in a wide arra...
How the Company Makes Money
Riken Vitamin makes money primarily by manufacturing and selling products in two broad categories: (1) food-related products and ingredients and (2) industrial/chemical functional materials. In the food domain, revenue is generated from supplying sea...
Riken Vitamin Co., Ltd. Financial Statement Overview
Summary
Balance sheet strength (score 85) offsets weaker income statement (52) and cash flow (45), resulting in a moderate overall financial score. The company has low debt and solid equity, but recent declines in profitability and cash generation pose challenges.
Income Statement
52NeutralBalance Sheet
85Very PositiveCash Flow
45Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.18B | 96.30B | 95.58B | 91.48B | 88.75B | 79.23B |
| Gross Profit | 30.14B | 29.77B | 31.27B | 29.89B | 27.24B | 25.57B |
| EBITDA | 11.90B | 11.58B | 16.04B | 15.35B | 11.71B | 24.23B |
| Net Income | 7.08B | 7.04B | 9.39B | 8.76B | 6.41B | 21.58B |
Balance Sheet | ||||||
| Total Assets | 117.34B | 116.39B | 113.00B | 118.78B | 105.22B | 102.66B |
| Cash, Cash Equivalents and Short-Term Investments | 17.91B | 20.07B | 22.30B | 23.38B | 19.16B | 17.30B |
| Total Debt | 7.40B | 7.14B | 9.98B | 16.09B | 14.60B | 17.57B |
| Total Liabilities | 32.94B | 33.01B | 33.80B | 42.13B | 33.85B | 36.12B |
| Stockholders Equity | 84.36B | 83.34B | 79.16B | 76.61B | 71.34B | 66.52B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 925.00M | 3.12B | 7.42B | 5.67B | 3.44B |
| Operating Cash Flow | 0 | 5.96B | 7.89B | 10.45B | 7.83B | 6.82B |
| Investing Cash Flow | 0 | 1.75B | 353.00M | -554.00M | -2.03B | -3.66B |
| Financing Cash Flow | 0 | -8.04B | -9.96B | -7.08B | -4.58B | -7.57B |
Riken Vitamin Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4526, the sentiment is Positive. The current price of 3440.00 is above the 20-day moving average (MA) of 3229.00, above the 50-day MA of 3247.36, and above the 200-day MA of 3008.20, indicating a bullish trend. The MACD of 56.26 indicates Negative momentum. The RSI at 68.00 is Neutral, neither overbought nor oversold. The STOCH value of 91.97 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4526.
Riken Vitamin Co., Ltd. Peers Comparison
Overall Rating
- JP:452670Outperform
JP:280263Neutral
JP:313960Neutral
JP:226459Neutral
JP:260757Neutral
JP:292751Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4526 | 70Outperform | JPY 78.33B | 14.26 | ― | 3.20% | 3.11% | -17.81% |
| JP:2802 | 63Neutral | JPY 4.79T | 35.65 | 18.50% | 0.96% | 6.72% | 83.84% |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| JP:3139 | 60Neutral | JPY 34.69B | 9.82 | ― | 4.26% | 5.61% | -15.32% |
| JP:2264 | 59Neutral | JPY 352.47B | 14.55 | ― | 2.34% | 1.89% | 227.30% |
| JP:2607 | 57Neutral | JPY 391.30B | 29.37 | ― | 1.24% | 9.93% | 1562.32% |
| JP:2927 | 51Neutral | JPY 12.09B | 10.22 | ― | 4.72% | 5.11% | -19.41% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4526 | Riken Vitamin Co., Ltd. | 3440.00 | 722.74 | 26.60% | |
| JP:2802 | Ajinomoto Co | 5128.00 | 735.56 | 16.75% | |
| JP:2264 | Morinaga Milk Industry Co., Ltd. | 1102.00 | 292.74 | 36.17% | |
| JP:2607 | Fuji Oil Holdings, Inc. | 4600.00 | 1477.54 | 47.32% | |
| JP:2927 | AFC-HD AMS Life Science Co., Ltd. | 848.00 | 41.06 | 5.09% | |
| JP:3139 | Lacto Japan Co., Ltd. | 3475.00 | 123.86 | 3.70% |
Riken Vitamin Co., Ltd. Corporate Events
Riken Vitamin Lifts Q1 Sales, Expands Capacity as Overseas Business Returns to Profit
Riken Vitamin reported an 8.1% year-on-year rise in first-quarter net sales to ¥25.1 billion, with growth across domestic food, domestic chemical, and overseas segments, while operating profit slipped 4.9% due mainly to higher costs and a ¥...
Riken Vitamin Lifts Sales but Sees Margin Pressure in Q1, Keeps Dividend Outlook Steady
Riken Vitamin Co., Ltd. reported consolidated net sales of ¥25.1 billion for the quarter ended June 30, 2026, up 8.1% year on year, while operating profit slipped 4.9% to ¥2.25 billion and ordinary profit was essentially flat, resulting in...
Riken Vitamin Advances Share Buyback, Acquires Over 350,000 Shares
Riken Vitamin Co., Ltd. has reported progress on its ongoing share buyback program, acquiring 192,500 shares of common stock on the Tokyo Stock Exchange between July 1 and July 31, 2026, at a total cost of about 606 million yen. This activity forms p...
Riken Vitamin Reports Progress on Share Buyback Program
Riken Vitamin Co., Ltd. has disclosed the progress of its share buyback program, reporting the acquisition of 165,800 shares of its common stock on the Tokyo Stock Exchange between June 1 and June 30, 2026, at a total cost of approximately 487 millio...
Riken Vitamin Raises Annual Dividend as Payout Climbs to ¥110 per Share
Riken Vitamin Co., Ltd. will pay a year-end dividend of ¥55 per share for the fiscal year ended March 31, 2026, matching its latest forecast and exceeding the prior year’s ¥53.50. The total year-end payout amounts to ¥1,615 milli...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026